Furukawa Taiji, Miura Reiko, Honda Mitsuyoshi, Kamiya Natsuko, Mori Yasuo, Takeshita Satoshi, Isshiki Takaaki, Nukada Toshihide
Department of Internal Medicine, Teikyo University School of Medicine 2-11-1 Kaga, Itabashi-ku, Tokyo 173-0003, Japan.
Br J Pharmacol. 2004 Dec;143(8):1050-7. doi: 10.1038/sj.bjp.0705944. Epub 2004 Nov 15.
Efonidipine, a derivative of dihydropyridine Ca(2+) antagonist, is known to block both L- and T-type Ca(2+) channels. It remains to be clarified, however, whether efonidipine affects other voltage-dependent Ca(2+) channel subtypes such as N-, P/Q- and R-types, and whether the optical isomers of efonidipine have different selectivities in blocking these Ca(2+) channels, including L- and T-types. To address these issues, the effects of efonidipine and its R(-)- and S(+)-isomers on these Ca(2+) channel subtypes were examined electrophysiologically in the expression systems using Xenopus oocytes and baby hamster kidney cells (BHK tk-ts13). Efonidipine, a mixture of R(-)- and S(+)-isomers, exerted blocking actions on L- and T-types, but no effects on N-, P/Q- and R-type Ca(2+) channels. The selective blocking actions on L- and T-type channels were reproduced by the S(+)-efonidipine isomer. By contrast, the R(-)-efonidipine isomer preferentially blocked T-type channels. The blocking actions of efonidipine and its enantiomers were dependent on holding potentials. These findings indicate that the R(-)-isomer of efonidipine is a specific blocker of the T-type Ca(2+) channel.
依福地平是一种二氢吡啶类钙(2+)拮抗剂衍生物,已知可阻断L型和T型钙(2+)通道。然而,依福地平是否会影响其他电压依赖性钙(2+)通道亚型,如N型、P/Q型和R型,以及依福地平的光学异构体在阻断这些钙(2+)通道(包括L型和T型)时是否具有不同的选择性,仍有待阐明。为了解决这些问题,在使用非洲爪蟾卵母细胞和幼仓鼠肾细胞(BHK tk-ts13)的表达系统中,通过电生理学方法研究了依福地平及其R(-)-和S(+)-异构体对这些钙(2+)通道亚型的影响。依福地平是R(-)-和S(+)-异构体的混合物,对L型和T型通道有阻断作用,但对N型、P/Q型和R型钙(2+)通道无影响。S(+)-依福地平异构体重现了对L型和T型通道的选择性阻断作用。相比之下,R(-)-依福地平异构体优先阻断T型通道。依福地平及其对映体的阻断作用取决于钳制电位。这些发现表明,依福地平的R(-)-异构体是T型钙(2+)通道的特异性阻滞剂。